A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer. The research also aims to identify methods to intercept this spread. The Peer-Reviewed Cancer Research Program (PRCRP) Idea Award funds innovative, high-risk, high-reward basic cancer research.
EIPM's 3Q External Newsletter
October 6, 2023
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our third quarterly external newsletter of 2023!
October 2023 EIPM Director's Memo
October 2, 2023
Dear Members of the Englander Institute,
Thank you all so much for a very successful and productive September!
I'm thrilled to share that the Englander Institute for Precision Medicine will host the 20th International Cancer Genome Consortium Scientific Workshopfrom November 7-9. The program is still coming together and we hope to share additional information with you soon.
September 2023 EIPM Director's Memo
September 7, 2023
Dear Members of the Englander Institute,
Thank you all so much for another very successful and productive month!
National Organization for Rare Disorders Designates Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center as a Rare Disease Center of Excellence
September 7, 2023
Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The designation adds the academic medical center to NORD’s collaborative network of 40 participating institutions that research and treat rare diseases.
A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer
August 23, 2023
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.
Severe COVID-19 Can Alter Long-term Immune System Response
August 17, 2023
Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing long-lasting alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators. The finding could help explain symptoms of prolonged inflammation and “long COVID” in people who have had the disease.
Mineralization of bone matrix regulates tumor cell growth
August 11, 2023
Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have been studied to understand why the activation occurs, from cells and molecules to other components in the so-called tissue microenvironment.
A Doctors Journey to Africa to Treat Breast Cancer Patients
August 3, 2023
"This work is my heart and soul," says Dr. Lisa Newman.
Taking care of breast cancer patients is her passion and one that led her and her colleagues to travel nearly 5,000 miles to Africa several times a year to see patients and help train and supply local doctors and clinics.
Her motivation for starting international breast cancer research in Africa was driven by the disparities observed among African American women in the United States.
July 2023 EIPM Director's Memo
July 6, 2023
Dear Members of the Englander Institute,
Thank you all so much for another very successful and productive month!
I hope you enjoy reading about June’s accomplishments, that include new awards, news coverage of our work, abstracts presented at ASCO, recaps of meetings, and impressive publications by a range of our EIPM colleagues!